Bayer expands its plant in Alcalá de Henares24 January 2018
It invests one million euros to increase its productive capacity and storage space
Bayer's Berlimed plant in Alcalá de Henares (Madrid) will receive an investment of almost one million euros to be used to extend its facilities. This amount is expected to complete the investment made in 2017, with which it set up two new production lines that increased its productive capacity by almost 40%.
This new phase of the expansion consists of building a new storage and transfer warehouse to improve the efficiency, security and ergonomics of the plant. The new works were started late last year and are expected to be completed in the third quarter of 2018.
The plant in Alcalá de Henares is a center of reference for the multinational, and concentrates the manufacturing and development of soft gelatin capsules used by the group all over the world. It is also considered one of the most modern production centers for pharmaceutical specialties in Europe. It exports around 90% of its output.
According to Manuel Martínez Jorge, general manager of the facility: “The construction of a new building represents a significant support for the enhanced production capacity of the Berlimed plant, and offers us a great opportunity to continue achieving new goals and innovating to extend our product portfolio”.
In 2017 saw completion of another extension of the plant, consisting the creation of two new high-speed lines that increased its production potential by 40%. This work was undertaken to meet the growth in demand and the planned new launches in coming years.
The Bayer plant, one of the pharmaceutical company's three production centers in Spain, is also working on an R&D project to develop a new capsule technology in collaboration with the Consejo Superior de Investigaciones Científicas (The Spanish National Research Council - CSIC).